Determination of drugs in biological samples by thin-layer chromatography-tandem mass spectrometry.
In this work thin-layer chromatography-tandem mass spectrometry (TLC-MS-MS) allowed detection and confirmation of caffeine and nicotine in human urine and of butorphanol, betamethasone, and clenbuterol in equine urine. In most cases of trace analysis of labile compounds the drugs could not be identified unless they were developed on a TLC plate, scraped from the plate and the TLC scrape eluted with a suitable organic solvent prior to MS-MS. Usually a sample prepared in this way still had several components in it, but was sufficiently cleaned up to allow collision-induced dissociation (CID) experiments to unequivocally identify the drug. In contrast, trace levels of labile drugs could not be identified by CID experiments either directly from the raw urine extracts or by thermally desorbing them from the TLC scrape.
D000818:Animals; D001623:Betamethasone / Q000652:urine; D002077:Butorphanol / Q000652:urine; D002110:Caffeine / Q000652:urine; D002855:Chromatography, Thin Layer / Q000379:methods; D002976:Clenbuterol / Q000652:urine; D006736:Horses; D006801:Humans; D013058:Mass Spectrometry / Q000379:methods; D004364:Pharmaceutical Preparations / Q000652:urine*
D004364:Pharmaceutical Preparations; D002110:Caffeine; D001623:Betamethasone; D002077:Butorphanol; D002976:Clenbuterol